lunes, 11 de junio de 2018

Drug pricing advocates take aim at Democrats for supporting pharma

JUNE 11, 2018

WASHINGTON — Fifty congressional Democrats signed on to a letter advancing the pharmaceutical industry’s talking points — and now a drug pricing advocacy group is calling them out.

Patients for Affordable Drugs sent a letter this morning to Speaker Paul Ryan and House Minority Leader Nancy Pelosi, along with the 50 Democrats, condemning the members who signed on to a separate May 24 missive that supports one of the drug industry’s chief lobbying priorities: a change to their financial liability in the so-called “donut hole.”